摘要
流行性感冒和相关流行病是一个严重的公共卫生问题。一些预防和治疗的的药物被用来组织它的传播,包括疫苗接种和治疗剂(例如奥司他韦,扎那米韦,以及在几个国家获得许可的帕拉米韦和拉尼米韦)和金刚烷(例如金刚烷胺和金刚乙胺)的几种预防和治疗措施。然而,神经氨酸酶抑制剂和金刚烷耐药病毒已被发现,而疫苗表现出应变的具体影响和有限的供应。因此,需要新的方法来预防和治疗流感感染。儿茶素,一类存在于茶叶中的多酚类黄酮,已经基于实验和临床研究被报道为潜在的抗流感病毒剂。(-)-表没食子儿茶素没食子酸酯(EGCG),一种主要和高度生物活性的儿茶素,已知在Madin-Darby犬肾细胞中抑制甲型和乙型流感病毒感染。此外,EGCG和其他儿茶素化合物如表儿茶素没食子酸酯和儿茶素-5-没食子酸酯也显示出通过分子对接证明的神经氨酸酶抑制活性。这些儿茶素可以不同地结合神经氨酸酶并且可以克服已知的药物抗性相关的病毒突变。此外,还研究了化学修饰的儿茶素衍生物的抗病毒作用,并且将来基于结构的儿茶素衍生物的药物设计研究可能有助于流感预防和治疗的改善。本次审查简要总结标的儿茶素的抗流感病毒感染和流感的预防和治疗的临床益处的抑制作用可能机制。此外,描述了茶儿茶素及其化学衍生物作为有效的抗病毒剂的巨大潜力。
关键词: 流感,绿茶,儿茶素,生物活性,构效关系,临床研究。
Current Medicinal Chemistry
Title:Anti-influenza Virus Effects of Catechins: A Molecular and Clinical Review
Volume: 23 Issue: 42
Author(s): Kazuke Ide, Yohei Kawasaki, Koji Kawakami, Hiroshi Yamada
Affiliation:
关键词: 流感,绿茶,儿茶素,生物活性,构效关系,临床研究。
摘要: Influenza infection and associated epidemics represent a serious public health problem. Several preventive and curative measures exist against its spread including vaccination and therapeutic agents such as neuraminidase inhibitors (e.g., oseltamivir, zanamivir, as well as peramivir and laninamivir, which are licensed in several countries) and adamantanes (e.g., amantadine and rimantadine). However, neuraminidase inhibitor- and adamantane- resistant viruses have been detected, whereas vaccines exhibit strain-specific effects and are limited in supply. Thus, new approaches are needed to prevent and treat influenza infections. Catechins, a class of polyphenolic flavonoids present in tea leaves, have been reported as potential anti-influenza virus agents based on experimental and clinical studies. (−)-epigallocatechin gallate (EGCG), a major and highly bioactive catechin, is known to inhibit influenza A and B virus infections in Madin-Darby canine kidney cells. Additionally, EGCG and other catechin compounds such as epicatechin gallate and catechin-5-gallate also show neuraminidase inhibitory activities as demonstrated via molecular docking. These catechins can bind differently to neuraminidase and might overcome known drug resistancerelated virus mutations. Furthermore, the antiviral effects of chemically modified catechin derivatives have also been investigated, and future structure-based drug design studies of catechin derivatives might contribute to improvements in influenza prevention and treatment. This review briefly summarizes probable mechanisms underlying the inhibitory effects of tea catechins against influenza infection and their clinical benefits on influenza prevention and treatment. Additionally, the great potential of tea catechins and their chemical derivatives as effective antiviral agents is described.
Export Options
About this article
Cite this article as:
Kazuke Ide, Yohei Kawasaki, Koji Kawakami, Hiroshi Yamada , Anti-influenza Virus Effects of Catechins: A Molecular and Clinical Review, Current Medicinal Chemistry 2016; 23 (42) . https://dx.doi.org/10.2174/0929867324666161123091010
DOI https://dx.doi.org/10.2174/0929867324666161123091010 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Diagnosis of Systemic Lupus Erythematosus in an Unusual Presentation: What a Primary Care Physician Should Know
Current Rheumatology Reviews Development of Global Consensus of Dengue Virus Envelope Glycoprotein for Epitopes Based Vaccine Design
Current Computer-Aided Drug Design Imaging Methods in Gene Therapy of Cancer
Current Gene Therapy Engineered Probiotic and Prebiotic Nutraceutical Supplementations in Combating Non-communicable Disorders: A Review
Current Pharmaceutical Biotechnology The Role of Macrophage Migration Inhibitory Factor in Critical Illness
Mini-Reviews in Medicinal Chemistry Potential Therapeutic Application of Chondroitin Sulfate/Dermatan Sulfate
Current Drug Discovery Technologies Binding Modes of 2-Phenylamino-6-oxopurines to Herpes Simplex Virus Thymidine Kinases
Letters in Drug Design & Discovery MicroRNAs in Human Virus Genomes: Helping Hands for Viral Infection
MicroRNA The Beneficial Role of Vitamin D in Human Immunodeficiency Virus Infection
Current HIV Research Immunotherapy, Vascular Pathology, and Microhemorrhages in Transgenic Mice
CNS & Neurological Disorders - Drug Targets SARS-CoV-2 Induced Neurological Manifestations Entangles Cytokine Storm that Implicates for Therapeutic Strategies
Current Medicinal Chemistry Cellular Delivery In Vivo of siRNA-Based Therapeutics
Current Pharmaceutical Design Immunobiology of Herpes Simplex Virus and Cytomegalovirus Infections of the Fetus and Newborn
Current Immunology Reviews (Discontinued) Interleukin 10 in Antiviral Responses
Current Immunology Reviews (Discontinued) Regulation of Apoptosis by Gram-Positive Bacteria: Mechanistic Diversity and Consequences for Immunity
Current Immunology Reviews (Discontinued) Structure, Biological Properties and Applications of Marine-derived Polysaccharides
Current Organic Chemistry Current Concepts on Selected Plant Secondary Metabolites With Promising Inhibitory Effects Against Enzymes Linked to Alzheimer’s Disease
Current Medicinal Chemistry Therapeutic Approach to Multiple Sclerosis by Novel Oral Drugs
Recent Patents on Inflammation & Allergy Drug Discovery The Usefulness and Challenges of Transgenic Mouse Models in the Study of Alzheimers Disease
CNS & Neurological Disorders - Drug Targets Autoantibodies Among HIV-1 Infected Individuals and the Effect of Anti-Retroviral Therapy (ART) on It
Current HIV Research